Table 3 Overall Survival (OS)
From: Clinical markers of immunotherapy outcomes in advanced sarcoma
Overall Survival | |
|---|---|
Category | Median OS, in weeks (range, in weeks) |
Single-agent ICI | 37 (33–41) |
ICI + combination | 64 (38–90) |
3 or more cycles; any ICI regimen | 74 (55–93) |
Less than 3 cycles; any ICI regimen | 12 (5–20) |
NLR < 5 | 60 (41–79) |
NLR ≥ 5 | 11 (0–34) |